Structure-Activity Relationships of the Enterococcal Cytolysin.

Enterococcal cytolysin is a hemolytic virulence factor linked to human disease and increased patient mortality. Produced by pathogenic strains of Enterococcus faecalis, cytolysin is made up of two small, post-translationally modified peptides called CylLL" and CylLS". They exhibit a unique toxicity profile where lytic activity is observed for both mammalian cells and Gram-positive bacteria that is dependent on the presence of both peptides. In this study, we performed alanine substitution of all residues in CylLL" and CylLS" and determined the effect on both activities. We identified key residues involved in overall activity and residues that dictate cell type specificity. All (methyl)lanthionines as well as a Gly-rich hinge region were critical for both activities. In addition, we investigated the binding of the two subunits to bacterial cells suggesting that the large subunit CylLL" has stronger affinity for the membrane or a target molecule therein. Genome mining identified other potential two-component lanthipeptides and provided insights into potential evolutionary origins.

[1]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation , 2021, Nucleic Acids Res..

[2]  Douglas A. Mitchell,et al.  Precursor peptide-targeted mining of more than one hundred thousand genomes expands the lanthipeptide natural product family , 2020, bioRxiv.

[3]  R. Bataller,et al.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease , 2019, Nature.

[4]  Li Wang,et al.  CylA is a sequence-specific protease involved in toxin biosynthesis , 2019, Journal of Industrial Microbiology & Biotechnology.

[5]  Y. Arafat,et al.  Molecular Mechanism of Quorum-Sensing in Enterococcus faecalis: Its Role in Virulence and Therapeutic Approaches , 2017, International journal of molecular sciences.

[6]  W. A. van der Donk,et al.  Synthesis and Bioactivity of Diastereomers of the Virulence Lanthipeptide Cytolysin. , 2016, Organic letters.

[7]  D. Fairlie,et al.  Stapling peptides using cysteine crosslinking , 2016, Biopolymers.

[8]  Liujie Huo,et al.  Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic , 2016, Journal of the American Chemical Society.

[9]  A. von Haeseler,et al.  IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies , 2014, Molecular biology and evolution.

[10]  K. Houk,et al.  Substrate Control in Stereoselective Lanthionine Biosynthesis , 2014, Nature chemistry.

[11]  J. Vederas,et al.  Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids. , 2014, Journal of the American Chemical Society.

[12]  L. Walensky,et al.  Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress , 2014, Journal of medicinal chemistry.

[13]  Melissa J. Martin,et al.  Structure, Function, and Biology of the Enterococcus faecalis Cytolysin , 2013, Toxins.

[14]  Weixin Tang,et al.  The Sequence of the Enterococcal Cytolysin Imparts Unusual Lanthionine Stereochemistry , 2013, Nature chemical biology.

[15]  Yi-Zun Yu,et al.  Evolution of lanthipeptide synthetases , 2012, Proceedings of the National Academy of Sciences.

[16]  D. Kohda,et al.  Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. , 2012, Journal of the American Chemical Society.

[17]  S. Walker,et al.  Haloduracin α Binds the Peptidoglycan Precursor Lipid II with 2:1 Stoichiometry , 2011, Journal of the American Chemical Society.

[18]  W. A. van der Donk,et al.  Insights into the Mode of Action of the Two-Peptide Lantibiotic Haloduracin , 2009, ACS chemical biology.

[19]  W. A. van der Donk,et al.  Structure-activity relationship studies of the two-component lantibiotic haloduracin. , 2008, Chemistry & biology.

[20]  Toshihide Kobayashi,et al.  Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin. , 2007, Biophysical journal.

[21]  D. Drider,et al.  Carnobacterium: positive and negative effects in the environment and in foods , 2007, FEMS microbiology reviews.

[22]  Huey W. Huang.  Molecular mechanism of antimicrobial peptides: the origin of cooperativity. , 2006, Biochimica et biophysica acta.

[23]  H. Sahl,et al.  The mode of action of the lantibiotic lacticin 3147 – a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II , 2006, Molecular microbiology.

[24]  M. Gilmore,et al.  Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. , 2005, Current protein & peptide science.

[25]  M. Gilmore,et al.  Enterococcus faecalis Senses Target Cells and in Response Expresses Cytolysin , 2004, Science.

[26]  M. Gilmore,et al.  Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction , 2002, Nature.

[27]  O. Kuipers,et al.  Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.

[28]  M. Gilmore,et al.  Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. , 1998, Emerging infectious diseases.

[29]  M. Gilmore,et al.  Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants , 1994, Journal of bacteriology.

[30]  J. van Oostrum,et al.  Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. , 1991, Biochemical pharmacology.

[31]  M. Gilmore,et al.  Molecular characterization of the Enterococcus faecalis cytolysin activator , 1991, Infection and immunity.

[32]  M. Gilmore,et al.  An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/bacteriocin , 1990, Infection and immunity.